Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model

  • Authors:
    • Jiarong Chen
    • Liu Yang
    • Lin Guo
    • Xiaojun Duan
  • View Affiliations

  • Published online on: July 3, 2012     https://doi.org/10.3892/etm.2012.629
  • Pages: 430-434
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Graft remodeling following anterior cruciate ligament (ACL) reconstruction requires a long period of recovery in which vascular endothelial growth factor (VEGF) plays an important role. The short half-life of exogenous VEGF, however, restricts its use. The aim of this study was to investigate sodium hyaluronate (SH) as a delivery system for VEGF in graft revascularization. Non-cumulative release into phosphate-buffered saline (PBS) was firstly measured spectrophotometrically for 1-4 days. Allogeneic bone-patellar tendon-bone (B-PT-B) was soaked in the VEGF/SH formulation and implanted in a rabbit model to regenerate the ACL and observe the vascularization and biomechanical properties. The results revealed that a steady state was achieved after ~40 h in non-cumulative measurements. The release plotted as a function of the square root of time was consistent with a largely diffusion-controlled release system. At 2, 4 and 8 weeks, the microvessel density of grafts was higher in the VEGF/SH-treated group compared to the control groups. Although there was a temporary decline at 2 weeks, the stiffness and maximum tensile load of the experimental group was significantly greater than that of the control group at 4 and 8 weeks (P<0.01). Our findings suggest that SH can be used as a good carrier of VEGF, which can improve the early revascularization and biomechanical properties of B-PT-B allografts after ACL reconstruction.
View Figures
View References

Related Articles

Journal Cover

September 2012
Volume 4 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Yang L, Guo L and Duan X: Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model. Exp Ther Med 4: 430-434, 2012.
APA
Chen, J., Yang, L., Guo, L., & Duan, X. (2012). Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model. Experimental and Therapeutic Medicine, 4, 430-434. https://doi.org/10.3892/etm.2012.629
MLA
Chen, J., Yang, L., Guo, L., Duan, X."Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model". Experimental and Therapeutic Medicine 4.3 (2012): 430-434.
Chicago
Chen, J., Yang, L., Guo, L., Duan, X."Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model". Experimental and Therapeutic Medicine 4, no. 3 (2012): 430-434. https://doi.org/10.3892/etm.2012.629